The impact of the COVID-19 pandemic on drug indicators at European level

28 Apr 2021

Online

Event type: Meeting

The Director the of the EMCDDA Mr Alexis Goosdeel participates at the virtual meeting: 'The impact of the COVID-19 pandemic on drug indicators at European level', organised by the Spanish Observatory on Drugs.

Spotlight

Supporting the hepatitis C elimination agenda – a toolkit to increase access to testing and care in drug services

Council approves EU Drugs Action Plan 2021–2025

Graphic shows a series of pie charts for cannabis, cocaine, MDMA and amphetamines, showing drug prevalance rates in the EU. Cannabis is the most used drug with 7.7% of adults having used it in the last year. Last year use for cocaine is 1.2%, MDMA is 0.9%

European Drug Report 2021

yellow and white pills on a light grey background

New benzodiazepines in Europe report

Wastewater analysis and drugs — a European multi-city study

COVID-19 and drugs

Subscribe to our Drugnet Europe monthly news round-up

The impact of the COVID-19 pandemic on drug indicators at European level

Main subject

Keywords

Target audience

Spotlight